Early Safety Assessment
Argenta’s models can provide information on the potential safety of compounds under pre-clinical investigation. Such information is essential in understanding the suitability of a particular compound as a Candidate Drug. Early assessment empowers drug discovery organisations with key data, prior to committing time and resource on expensive pre-clinical development.
For more information on our early safety assessment capabilities please contact us.